Aims: To investigate whether the transfusion of immune spleen lymphocytes with dendritic cells (DC) based cancer vaccines could induce adoptive antitumor immunopreventive (AIP) and immunotherapeutic (AIT) effects.Methods:Previous studies of our laboratory have demonstrated that vaccination of normal and tumor bearing mice with fused cells of bone marrow derived DC with NS 1 myeloma cells and with DCs pulsed with the tumor lysates in vitro can induce host in vivo antitumor immune reponses.In this study,...